Borland Michael G, Foreman Jennifer E, Girroir Elizabeth E, Zolfaghari Reza, Sharma Arun K, Amin Shantu, Gonzalez Frank J, Ross A Catharine, Peters Jeffrey M
Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, 312 Life Science Building, University Park, PA 16802, USA.
Mol Pharmacol. 2008 Nov;74(5):1429-42. doi: 10.1124/mol.108.050609. Epub 2008 Aug 7.
Although there is strong evidence that ligand activation of peroxisome proliferator-activated receptor (PPAR)-beta/delta induces terminal differentiation and attenuates cell growth, some studies suggest that PPARbeta/delta actually enhances cell proliferation. For example, it was suggested recently that retinoic acid (RA) is a ligand for PPARbeta/delta and potentiates cell proliferation by activating PPARbeta/delta. The present study examined the effect of ligand activation of PPARbeta/delta on cell proliferation, cell cycle kinetics, and target gene expression in human HaCaT keratinocytes using two highly specific PPARbeta/delta ligands [4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methylphenoxy acetic acid (GW0742) and 2-methyl-4-((4-methyl-2-(4-trifluoromethylphenyl)-1,3-thiazol-5-yl)-methylsulfanyl)phenoxy-acetic acid (GW501516)] and RA. Both PPARbeta/delta ligands and RA inhibited cell proliferation of HaCaT keratinocytes. GW0742 and GW501516 increased expression of known PPARbeta/delta target genes, whereas RA did not; RA increased the expression of known retinoic acid receptor/retinoid X receptor target genes, whereas GW0742 did not affect these genes. GW0742, GW501516, and RA did not modulate the expression of 3-phosphoinositide-dependent protein kinase or alter protein kinase B phosphorylation. GW0742 and RA increased annexin V staining as quantitatively determined by flow cytometry. The effects of GW0742 and RA were also examined in wild-type and PPARbeta/delta-null primary mouse keratinocytes to determine the specific role of PPARbeta/delta in modulating cell growth. Although inhibition of keratinocyte proliferation by GW0742 was PPARbeta/delta-dependent, inhibition of cell proliferation by RA occurred in both genotypes. Results from these studies demonstrate that ligand activation of PPARbeta/delta inhibits keratinocyte proliferation through PPARbeta/delta-dependent mechanisms. In contrast, the observed inhibition of cell proliferation in mouse and human keratinocytes by RA is mediated by PPARbeta/delta-independent mechanisms and is inconsistent with the notion that RA potentiates cell proliferation by activating PPARbeta/delta.
尽管有强有力的证据表明过氧化物酶体增殖物激活受体(PPAR)-β/δ的配体激活可诱导终末分化并减弱细胞生长,但一些研究表明PPARβ/δ实际上会增强细胞增殖。例如,最近有人提出视黄酸(RA)是PPARβ/δ的一种配体,可通过激活PPARβ/δ来增强细胞增殖。本研究使用两种高度特异性的PPARβ/δ配体[4-[[[2-[3-氟-4-(三氟甲基)苯基]-4-甲基-5-噻唑基]甲基]硫代]-2-甲基苯氧基乙酸(GW0742)和2-甲基-4-((4-甲基-2-(4-三氟甲基苯基)-1,3-噻唑-5-基)-甲基硫烷基)苯氧基乙酸(GW501516)]以及RA,研究了PPARβ/δ的配体激活对人HaCaT角质形成细胞的细胞增殖、细胞周期动力学和靶基因表达的影响。PPARβ/δ配体和RA均抑制了HaCaT角质形成细胞的增殖。GW0742和GW501516增加了已知PPARβ/δ靶基因的表达,而RA则没有;RA增加了已知视黄酸受体/维甲酸X受体靶基因的表达,而GW0742对这些基因没有影响。GW0742、GW501516和RA均未调节3-磷酸肌醇依赖性蛋白激酶的表达,也未改变蛋白激酶B的磷酸化。通过流式细胞术定量测定,GW0742和RA增加了膜联蛋白V染色。还在野生型和PPARβ/δ基因敲除的原代小鼠角质形成细胞中研究了GW0742和RA的作用,以确定PPARβ/δ在调节细胞生长中的具体作用。尽管GW0742对角质形成细胞增殖的抑制是PPARβ/δ依赖性的,但RA对细胞增殖的抑制在两种基因型中均会发生。这些研究结果表明,PPARβ/δ的配体激活通过PPARβ/δ依赖性机制抑制角质形成细胞增殖。相比之下,观察到的RA对小鼠和人角质形成细胞增殖的抑制是由PPARβ/δ非依赖性机制介导的,这与RA通过激活PPARβ/δ增强细胞增殖的观点不一致。